Mast cell sarcoma: A rare and potentially under-recognized diagnostic entity with specific therapeutic implications

Modern Pathology

Volumn 26, Issue 4, 2013, Pages 533-543

  Ryan, Russell J H ^a   Akin, Cem ^b   Castells, Mariana ^b   Wills, Marcia ^c   Selig, Martin K ^a   Nielsen, G Petur ^a   Ferry, Judith A ^a   Hornick, Jason L ^b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Seacoast Pathology Aurora Diagnostics   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

imatinib; KIT mutation; mast cell sarcoma; mastocytosis; urticaria pigmentosa

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA2B INTERFERON; BLEOMYCIN; BORTEZOMIB; CARBOPLATIN; CLADRIBINE; CLOBETASOL; CLOFARABINE; CYTARABINE; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; IMATINIB; PAMIDRONIC ACID; PREDNISONE; VINBLASTINE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPITHELIOID CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANTILE CUTANEOUS MASTOCYTOSIS; LANGERHANS CELL HISTIOCYTOSIS; MALE; MASTOCYTOSIS; MOLECULARLY TARGETED THERAPY; MULTINUCLEAR CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SARCOMA;

AGED; CHILD; FEMALE; HUMANS; MALE; MAST-CELL SARCOMA; YOUNG ADULT;

EID: 84876481599     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.199     Document Type: Review

References (22)

1. Horny H-P, Metcalfe DD, Bennett JM, et al. In: Swerdlow SH, Campo E, Harris NL, et al. (eds) WHO classification of tumors of haematopoietic and lym-phoid tissues, 4th edn. International Agency for Research on Cancer: Lyon; 2008, pp 54-63.
2. Patnaik AK, Ehler WJ, MacEwan EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
3. Horny HP, Parwaresch MR, Kaiserling E, et al. Mast cell sarcoma of the larynx. J Clin Pathol 1986;39:596-602. (Pubitemid 16069663)
4. Kojima M, Nakamura S, Itoh H, et al. Mast cell sarcoma with tissue eosinophilia arising in the ascending colon. Mod Pathol 1999;12:739-743. (Pubitemid 29354889)
5. Chott A, Guenther P, Huebner A, et al. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma. Am J Surg 2003;27:1013-1019. (Pubitemid 36758906)
6. Brcić L, Vuletić LB, Stepan J, et al. Mast-cell sarcoma of the tibia. J Clin Pathol 2007;60:424-425. (Pubitemid 46596565)
7. Bugalia A, Abraham A, Balasubramanian P. Mast cell sarcoma of the small intestine: a case report. J Clin Pathol 2011;64:1035-1037.
8. Ma HB, Xu X, Liu WP, et al. Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol 2011;94:491-494.
9. Auquit-Auckbur I, Lazar C, Deneuve S, et al. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol 2012;36:779-782.
10. Kobayasi T, Midtgard K, Asboe-Hansen G. Ultrastruc-ture of human mast-cell granules. J Ultrastruct Res 1968;23:153-165.
11. Sperr WR, Escribano L, Jordan J, et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytologi-cal grading of mastocytosis. Leuk Res 2001;25: 529-536. (Pubitemid 32506759)
12. Fine HF, Akin C, Hematti P, et al. Presumed choroidal and orbital mastocytosis. Arch Ophthalmol 2001; 119:1716-1719. (Pubitemid 33035719)
13. Takemoto CM, Yoon YJ, Fisher DE. The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor. J Biol Chem 2002;277:30244-30252.
14. Tilly H, Gaulard P, Lepage E, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997;90: 3727-3734. (Pubitemid 27473445)
15. Sotlar K, Cerny-Reiterer S, Petat-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 2011;24: 585-595.
16. Pardanani A, Tefferi A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 2010;17:125-132.
17. Hoffmann KM, Moser A, Lohse P, et al. Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood 2008;112:1655-1657.
18. Soule BP, Brown JM, Kushnir-Sukhov NM, et al. Effects of gamma radiation on FceRI and TLR-mediated mast cell activation. J Immunol 2007;179: 3276-3286.
19. Bodemer C, Hermine O, Palmérini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2009;130:804-815.
20. Hu S, Kuo T, Hong HS. Mast cells with bilobed or multilobed nuclei in a nodular lesion of a patient with urticaria pigmentosa. Am J Dermatopathol 2002;24:490.
21. Tran DT, Jokinen CH, Argenyi ZB. Histiocyte-rich pleomorphic mastocytoma: an uncommon variant mimicking juvenile xanthogranuloma and Langerhans cell histiocytosis. J Cutan Pathol 2009;36:1215-1220.
22. Guenther PP, Huebner A, Sobottka SB, et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J Pediatr Hematol Oncol 2001;23:134-138. (Pubitemid 32162678)